Top compounds associated with response to NELFB


Feature Type Standardized
Nominal ANOVA
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.04 0.3
mRNA oligomycin a CTRPv2 pan-cancer AAC 0.04 0.3
mRNA LE-135 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.037 0.3
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA KIN001-135 GDSC1000 pan-cancer AAC 0.059 0.3
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.033 0.3
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.3
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC 0.052 0.3
Download CSV